Loading stock data…
UNH
$370.48-0.26 (-0.07%)
Pre-Market$370.59+0.11 (+0.03%)· Last close Apr 30
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
UnitedHealth Group Incorporated in the Healthcare sector is trading at $370.48. The stock is currently 10% below its 52-week high of $409.70, remaining 18.9% above its 200-day moving average. Technical signals show overbought RSI of 97 and bullish MACD crossover, explaining why UNH maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 97) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJPFEABBV
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$370.48
Potential Downside
15.8%
Whystock Fair Value$312.08
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus26 analysts
Buy
Mean target$387.27+4.5%
Range$287.00 – $444.00
Fundamentals
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care deliver...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$321.07B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.74
Beta
Defensive asset. Lower volatility than the S&P 500.
0.41
Div Yield
Strong income play. Yield provides a meaningful total return floor.
250.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
22.63%
Volume
Today's trading volume
6.84M
Recent News
Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.
UnitedHealth Stock Has Rallied Since Earnings. One Top Insider Is Trimming His Stake.
Optum CEO Patrick Conway sold $284,000 worth of stock shortly after earnings, marking his first sale of 2026.
Humana Q1 Earnings Call Highlights
Humana (NYSE:HUM) executives said the company’s first-quarter performance tracked as expected and reiterated its longer-term plan to rebuild Medicare Advantage profitability, while also outlining ongoing operational changes, balance-sheet actions, and growth initiatives at CenterWell. Management sa
CVS Earnings Are Coming. Why the Stock Is No Longer a Value Trap.
The stock trades at just 11 times earnings estimates for the next 12 months, much cheaper than rivals UnitedHealth and Humana.
Opinion: It's Time to Load Up on UnitedHealth Group Stock
The healthcare giant could be turning the corner after a rough patch.